5-{[(3-fluorophenyl)methyl]sulfanyl}-8,9-dimethoxy-3-(propan-2-yl)-2H,3H-imidazo[1,2-c]quinazolin-2-one

Catalog No. :
ACUAEL794
CAS No. :
1214102-54-1
Molecular Formula :
C22H22FN3O3S
Molecular Weight :
427.50

IUPAC Name:5-((3-fluorobenzyl)thio)-3-isopropyl-8,9-dimethoxyimidazo[1,2-c]quinazolin-2(3H)-one

5-{[(3-fluorophenyl)methyl]sulfanyl}-8,9-dimethoxy-3-(propan-2-yl)-2H,3H-imidazo[1,2-c]quinazolin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-{[(3-fluorophenyl)methyl]sulfanyl}-8,9-dimethoxy-3-(propan-2-yl)-2H,3H-imidazo[1,2-c]quinazolin-2-one
IUPAC Name5-((3-fluorobenzyl)thio)-3-isopropyl-8,9-dimethoxyimidazo[1,2-c]quinazolin-2(3H)-one
Molecular FormulaC22H22FN3O3S
Molecular Weight427.50
SMILESO=C(C1C(C)C)N=C2N1C(SCC3=CC=CC(F)=C3)=NC4=C2C=C(OC)C(OC)=C4
InChI KeyJIBGAQKPUCEYOB-UHFFFAOYSA-N
Synonym5-[(3-FLUOROBENZYL)SULFANYL]-3-ISOPROPYL-8,9-DIMETHOXYIMIDAZO[1,2-C]QUINAZOLIN-2(3H)-ONE;5-{[(3-fluorophenyl)methyl]sulfanyl}-8,9-dimethoxy-3-(propan-2-yl)-2H,3H-imidazo[1,2-c]quinazolin-2-one;Imidazo[1,2-c]quinazolin-2(3H)-one, 5-[[(3-fluorophenyl)methyl]thio]-8,9-dimethoxy-3-(1-methylethyl)-
CAS No.1214102-54-1

Synthetic Route by SureRoute

1. ACUAEL794 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUAEL794 route product structure diagram
    ACUAEL7941214102-54-1
Inquiry

2. ACUAEL794 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUAEL794 route product structure diagram
    ACUAEL7941214102-54-1
Inquiry

Comments (0)